News | October 10, 2013

Biotronik Launches Idova 7 ICD, Approved for MR Scanning

First worldwide implantations of the ultrahigh-energy device taking place in Italy and Austria

Biotronik Inc Idova 7 ICD MRI EP Lab Austria Italy

October 10, 2013 — Biotronik announced the launch of the new Idova 7 series. Idova 7 ICDs (implantable cardioverter-defibrillators) and CRT-Ds (cardiac resynchronization therapy defibrillators) offer ultrahigh-energy therapy without compromising on short charge times (10 seconds), smaller size (34 cc) and longevity of more than 11 years. Designed to stop life-threatening arrhythmias with the very first shock, Idova 7 gives patients valuable peace of mind.

As the only device on the market approved for (magnetic resonance imaging) MRI that is also able to offer 45 joule, Idova 7 is engineered to increase the success rate of the first shock and reduce the need for subsequent shocks. Idova 7 therefore enhances security for doctors and patients, offering them the promise of successful therapy from the very beginning.

“Ideally, a patient’s heart would react the same way to ICD therapy in real life as it would when tested after implantation. But that is not so often the case,” commented Dr. Clemens Steinwender, General Hospital Linz, Austria. “If I can give my patients that extra energy at the first shock, then I can assure them they are on the safe side.”

For ICD therapy to be successful, it is crucial to be aware of a patient’s defibrillation threshold (DFT), defined as the amount of energy required to shock the heart back to a normal rhythm. But DFT has a tendency to rise over time, and require higher amounts of energy. Higher DFTs can be caused by factors as widespread as prescribed medication, severely dilated hearts or young age and high activity levels.

“There are many variables that are related to the patient’s health and lifestyle, and not under my direct control. These can unfortunately affect defibrillation thresholds without our advanced knowledge,” explained Dr. Fabrizio Caravati, Hospital Fondazione Macchi of Varese, Italy. “It is important to be able to reassure patients that they have the maximum amount of energy at their disposal, in the event they should need it,” continued Dr. Paolo Bonfanti, Hospital Fondazione Macchi of Varese, Italy.

“After launching Ilesto and Iforia, we can now broaden our second generation of ProMRI devices with the ultrahigh-energy Idova 7 series,” commented Christoph Böhmer, president international at Biotronik. “Like all innovative Biotronik implants, Idova 7 will also be available with Biotronik Home Monitoring, which rapidly detects clinically relevant events like arrhythmias and can thereby prevent stroke and reduce hospitalization. In fact, the results of the recent IN-TIME study, introduced at this year’s ESC conference, demonstrated a significant reduction in all-cause mortality in heart failure patients with implant-based remote monitoring.”

For more information:

Related Content

The FDA has cleared the Toshiba Vantage Galan 3.0T XGO Edition MRI from Canon Medical Systems.
Technology | Magnetic Resonance Imaging (MRI) | February 12, 2018
February 12, 2018 — Physicians now have access to more neuro and cardiac ...
Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI) | January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI) | December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI) | December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI) | December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI) | October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI) | September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
Overlay Init